Dia 1

580 / 1196

• Preclinical rationale behind oligometastatic
state
• Clinical data supporting benefit to local
treatment in oligometastatic NSCLC
• Case report
• Discussion of current multidisciplinary
(physician, phisyc and RTTs) management